Results 171 to 180 of about 2,987,261 (338)

THE DESOXYRIBONUCLEIC ACID CONTENT OF ISOLATED NUCLEI OF TUMOR CELLS

, 1943
Alexander L. Dounce
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Precision Oncology Framework Using Circulating Tumor Cells. [PDF]

Int J Mol Sci
Kakizaki F, Oshiro K, Enoki Y, Kawanishi K, Masuda N, Maekawa H, Matsubayashi J, Kawashima M, Miyoshi H, Takemura Y, Obama K.   +10 more
europepmc   +1 more source

STUDIES ON THE EFFECTS OF ACTINOMYCETES PRODUCTS ON THE CULTURE OF HUMAN CARCINOMA CELLS (STRAIN HELA) I. THE EFFECT OF KNOWN ANTIBIOTICS HAVING NO OR SLIGHT TUMOR-INHIBITORY ACTIVITY ON HELA CELLS

, 1957
Kazuo Nitta
openalex   +2 more sources

ON THE MECHANISM OF INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS IN EHRLICH ASCITES TUMOR CELLS BY DEOXYADENOSINE IN VITRO [PDF]

, 1961
Kay Overgaard‐Hansen, Hans Klenow
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Hydrophobin-Coated Echogenic Microbubbles for Molecular Targeting of Tumor Cells. [PDF]

Adv Sci (Weinh)
Al-Terke HH, Beaune G, Junaid M, Seitsonen J, Paananen A, Metrangolo P, Timonen JVI, Joensuu J, Ras RHA.   +8 more
europepmc   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

β-catenin as a key regulator of the cisplatin response in tumor cells. [PDF]

Clin Exp Med
Saburi E, Moghbeli M.
europepmc   +1 more source

Inhibition of Tumor cell Glycolysis by DPNH₂, and Reversal of the Inhibition by DPN, Pyruvate or Methylene blue [PDF]

, 1963
Mark Woods, Dean Burk
openalex   +1 more source